New Results
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
View ORCID ProfileMichael K. Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, Mike Flint, James R. Beadle, Nadejda Valiaeva, Robert T. Schooley, View ORCID ProfileKarl Y. Hostetler, Joel M. Montgomery, Christina Spiropoulou
doi: https://doi.org/10.1101/2021.08.06.455494
Michael K. Lo
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
Punya Shrivastava-Ranjan
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
Payel Chatterjee
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
Mike Flint
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
James R. Beadle
bDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA
Nadejda Valiaeva
bDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA
Robert T. Schooley
bDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA
Karl Y. Hostetler
bDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA
Joel M. Montgomery
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA
Christina Spiropoulou
aViral Special Pathogens Branch, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia, USA

Article usage
Posted August 10, 2021.
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
Michael K. Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, Mike Flint, James R. Beadle, Nadejda Valiaeva, Robert T. Schooley, Karl Y. Hostetler, Joel M. Montgomery, Christina Spiropoulou
bioRxiv 2021.08.06.455494; doi: https://doi.org/10.1101/2021.08.06.455494
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
Michael K. Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, Mike Flint, James R. Beadle, Nadejda Valiaeva, Robert T. Schooley, Karl Y. Hostetler, Joel M. Montgomery, Christina Spiropoulou
bioRxiv 2021.08.06.455494; doi: https://doi.org/10.1101/2021.08.06.455494
Subject Area
Subject Areas
- Biochemistry (13889)
- Bioengineering (10592)
- Bioinformatics (33684)
- Biophysics (17349)
- Cancer Biology (14410)
- Cell Biology (20423)
- Clinical Trials (138)
- Developmental Biology (11004)
- Ecology (16235)
- Epidemiology (2067)
- Evolutionary Biology (20546)
- Genetics (13531)
- Genomics (18831)
- Immunology (13972)
- Microbiology (32607)
- Molecular Biology (13563)
- Neuroscience (71064)
- Paleontology (533)
- Pathology (2224)
- Pharmacology and Toxicology (3785)
- Physiology (5970)
- Plant Biology (12175)
- Synthetic Biology (3409)
- Systems Biology (8252)
- Zoology (1878)